(Q42141470)

English

Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for cl

scientific article published on December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 October 2017

Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for cl (English)

1 reference

Europe PubMed Central

17 October 2017

0 references

5

1 reference

Europe PubMed Central

17 October 2017

author name string

Joseph Nariculam

1

1 reference

Europe PubMed Central

17 October 2017

Alex Freeman

2

1 reference

Europe PubMed Central

17 October 2017

Simon Bott

3

1 reference

Europe PubMed Central

17 October 2017

Phillipa Munson

4

1 reference

Europe PubMed Central

17 October 2017

Nicola Brookman-Amissah

6

1 reference

Europe PubMed Central

17 October 2017

Magali Williamson

7

1 reference

Europe PubMed Central

17 October 2017

Roger S Kirby

8

1 reference

Europe PubMed Central

17 October 2017

John Masters

9

1 reference

Europe PubMed Central

17 October 2017

Mark Feneley

10

1 reference

Europe PubMed Central

17 October 2017

publication date

1 December 2008

1 reference

Europe PubMed Central

17 October 2017

Asian Journal of Andrology

1 reference

Europe PubMed Central

17 October 2017

11

1 reference

Europe PubMed Central

17 October 2017

1

1 reference

Europe PubMed Central

17 October 2017

109-118

1 reference

Europe PubMed Central

17 October 2017

Tissue microarray sampling strategy for prostate cancer biomarker analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Delineation of prognostic biomarkers in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

The p53 network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Molecular aspects of cancer metastasis: extracellular regulation of the E-cadherin/catenin complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Expression of E-cadherin in primary and metastatic prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

29 May 2018

p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

Nested case-control studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752526

17 August 2018

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of E-cadherin in primary prostate cancer: correlation with clinical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent prognostic importance of microvessel density in clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of p53, bcl-2 and E-cadherin expression in predicting biochemical relapse for organ confined prostate cancer in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19050681

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJA.2008.22

1 reference

Europe PubMed Central

17 October 2017

1 reference

Europe PubMed Central

17 October 2017

1 reference

Europe PubMed Central

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42141470&oldid=1564760762"